EXAGEN INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $66.6M | $55.6M | $52.5M | $45.6M | $48.3M |
| Gross profit | $38.8M | $33.1M | $29.5M | — | — |
| Operating income | -$14.1M | -$13.6M | -$22.8M | -$46.1M | -$24.1M |
| Cost of revenue | $27.8M | $22.5M | $23.1M | $24.2M | $20.6M |
| Cash from operations | -$13.6M | -$13.3M | -$14.5M | -$32.1M | -$20.3M |
| Capital expenditure | $641,000 | $515,000 | $828,000 | $4.3M | $2.4M |
| Free cash flow | -$14.3M | -$13.8M | -$15.3M | -$36.5M | -$22.6M |
| Share repurchases | — | — | — | — | $12.8M |
| Impairments | — | — | $0 | $5.5M | $0 |
| Total assets | $58.0M | $44.7M | $56.9M | $86.2M | $123.4M |
| Total liabilities | $40.6M | $35.1M | $34.2M | $43.8M | $38.5M |
Shares outstanding 24.2M · Free float 62.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.